Number of the records: 1  

Cryopreservation of Organoids

  1. 1.
    SYSNO ASEP0573693
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleCryopreservation of Organoids
    Author(s) Rogulska, Olena (FGU-C) ORCID, RID, SAI
    Havelková, Jarmila (FGU-C)
    Petrenko, Yuriy (FGU-C) ORCID, RID, SAI
    Source TitleCryo-letters. - : CryoLetters LLP - ISSN 0143-2044
    Roč. 44, č. 2 (2023), s. 65-75
    Number of pages11 s.
    Languageeng - English
    CountryGB - United Kingdom
    Keywordsorganoids ; stem cells ; tumour ; cryopreservation ; vitrification ; recovery
    OECD categoryBiomaterials (as related to medical implants, devices, sensors)
    R&D ProjectsGA21-06065S GA ČR - Czech Science Foundation (CSF)
    Method of publishingOpen access
    Institutional supportFGU-C - RVO:67985823
    UT WOS001006587700001
    EID SCOPUS85152269856
    DOI10.54680/fr23210110112
    AnnotationOrganoids represent indispensable opportunities for biomedicine, including drug discovery, cancer biology, regenerative and personalised medicine or tissue and organ transplantation. However, the lack of optimised preservation strategies limits the wide use of organoids in research or clinical fields. In this review, we present a short outline of the recent developments in organoid research and current cryopreservation strategies for organoid systems. While both vitrification and slow controlled freezing have been utilized for the cryopreservation of organoid structures or their precursor components, the controlled-rate slow freezing under protection of Me2 SO remains the most common approach. The application of appropriate pre- or post-treatment strategies, like the addition of Rho-kinase or myosin inhibitors into cell culture or cryopreservation medium, can increase the recovery of complex organoid constructs post-thaw. However, the high complexity of the organoid structure and heterogeneity of cellular composition bring challenges associated with cryoprotectant distribution, distinct response of cells to the solution and freezing-induced injuries. The deficit of adequate quality control methods, which may ensure the assessment of organoid recovery in due term without prolonged re-cultivation process, represents another challenge limiting the reproducibility of current cryobanking technology. In this review, we attempt to assess the current demands and achievements in organoid cryopreservation and highlight the key questions to focus on during the development of organoid preservation technologies.
    WorkplaceInstitute of Physiology
    ContactLucie Trajhanová, lucie.trajhanova@fgu.cas.cz, Tel.: 241 062 400
    Year of Publishing2024
    Electronic addresshttps://doi.org/10.54680/fr23210110112
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.